RT Journal Article
SR Electronic
T1 704 Biological activity of FLX475, an oral CCR4 antagonist, as monotherapy and in combination with pembrolizumab in advanced cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A799
OP A799
DO 10.1136/jitc-2023-SITC2023.0704
VO 11
IS Suppl 1
A1 Adamik, Juraj
A1 Grant, Adam
A1 Trujillo, Damian
A1 Goyal, Rakesh Kumar
A1 Ho, William
A1 Chisamore, Michael
A1 Ikeda, Shoji
A1 Au, Marvin
A1 Nagata, Denise
A1 Lurie, Eugene
A1 Zhu, Qingfeng
A1 Anders, Robert
A1 Brockstedt, Dirk G
A1 Ghomi, Mohsen Sabouri
A1 Kassner, Paul D
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A799.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.